Ascentage Pharma Group International (AAPG)

NASDAQ: AAPG · Real-Time Price · USD

24.05

-0.35 (-1.43%)

At close: Mar 18, 2026, 4:00 PM EDT

22.10

-1.95 (-8.11%)

Pre-market: Mar 19, 2026, 8:32 AM EDT

AAPG Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1,661	1,261	1,094	1,492	1,744	1,024
Cash & Short-Term Investments	1,661	1,261	1,094	1,492	1,744	1,024
Cash Growth	51.00%	15.30%	-26.70%	-14.43%	70.23%	16.09%
Accounts Receivable	78.36	83.14	145.89	54.36	53.97	-
Other Receivables	160.31	123.21	88.29	80.44	83.56	54.64
Total Trade Receivables	238.68	206.35	234.18	134.8	137.53	54.64
Inventory	8.59	6.6	16.17	9.45	3.93	-
Total Current Assets	1,909	1,474	1,344	1,636	1,885	1,079
Net Property, Plant & Equipment	871.96	905.56	957.07	1,004	844.37	477
Other Intangible Assets	70.99	76	85.45	84.3	60.41	66.41
Goodwill	24.69	24.69	24.69	24.69	24.69	24.69
Long-Term Investments	37.34	33.86	18.95	18.53	27.85	31.77
Other Long-Term Assets	132.44	103.54	70.06	62.1	97.46	52.12
Total Assets	3,046	2,618	2,500	2,830	2,940	1,731
Accounts Payable	118.68	91.97	72.45	95.56	70.86	23.36
Accrued Expenses	249.36	258.1	206.91	240.03	194.18	188.57
Short-Term Debt	833.78	779.06	616.4	518.38	49.45	50.56
Unearned Revenue	37.49	37.49	38.41	24.35	24.36	0.04
Other Current Liabilities	-	-	-	2.82	22.26	13.62
Total Current Liabilities	1,239	1,167	934.17	881.15	361.11	276.15
Long-Term Debt	882.38	889.44	1,179	1,274	1,035	479.13
Other Long-Term Liabilities	248.55	287.6	316.4	266.11	309.38	129.14
Total Long-Term Liabilities	1,131	1,177	1,496	1,540	1,344	608.27
Total Liabilities	2,370	2,344	2,430	2,422	1,705	884.42
Common Stock	0.24	0.21	0.2	0.18	0.18	0.15
Treasury Stock	-2.96	-0.01	-21.35	-26.55	-0	-0
Additional Paid-in Capital	7,546	-	-	-	-	-
Accumulated Other Comprehensive Income	-516.07	263.99	81.57	435.03	1,235	846.47
Retained Earnings	-6,361	-	-	-	-	-
Total Common Shareholders' Equity	666	264.19	60.42	408.66	1,235	846.62
Minority Interest	9.91	9.97	10.22	-	-	-
Shareholders' Equity	675.91	274.16	70.63	408.66	1,235	846.62
Total Liabilities & Equity	3,046	2,618	2,500	2,830	2,940	1,731
Total Debt	1,716	1,668	1,796	1,793	1,084	529.7
Net Cash (Debt)	-54.71	-407.29	-701.76	-300.49	659.53	494.71
Net Cash Growth	-	-	-	-	33.32%	-36.66%
Net Cash Per Share	-0.67	-5.39	-	-4.56	10.36	9.16
Book Value	666	264.19	60.42	408.66	1,235	846.62
Book Value Per Share	8.20	3.50	-	6.20	19.40	15.68
Tangible Book Value	570.31	163.5	-49.72	299.66	1,150	755.52
Tangible Book Value Per Share	7.02	2.17	-	4.55	18.06	14.00

Updated Sep 19, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q